Toshiba ultrasound used in clinical trial at John Hopkins
Toshiba America Medical Systems Inc. has inked an agreement to provide Johns Hopkins Bayview Medical Center its Aplio CV ultrasound system for use in a clinical trial to be untaken within the Department of Non-invasive Cardiac Imaging, the company said.
The Aplio CV is being used to to conduct a high-volume of cardiovascular echocardiography procedures. Under the terms of the agreement, the system will be used for 30 months during the study in conjunction with Toshiba's Aquilion 64 CFX, a volumetric 64-slice CT system.
The clinical trial, entitled "The Combined Use of Tissue Doppler Echo and Cardiac Multi-Detector CT to Assess Outcome Following Resynchronization Therapy," involves approximately 50 to 100 patients. The overall objective of the study is to utilize the combination of these modalities to optimize cardiac resynchronization, predict the adequacy of response to therapy and to study the effects of dyssynchrony, Toshiba said.
The Aplio CV is being used to to conduct a high-volume of cardiovascular echocardiography procedures. Under the terms of the agreement, the system will be used for 30 months during the study in conjunction with Toshiba's Aquilion 64 CFX, a volumetric 64-slice CT system.
The clinical trial, entitled "The Combined Use of Tissue Doppler Echo and Cardiac Multi-Detector CT to Assess Outcome Following Resynchronization Therapy," involves approximately 50 to 100 patients. The overall objective of the study is to utilize the combination of these modalities to optimize cardiac resynchronization, predict the adequacy of response to therapy and to study the effects of dyssynchrony, Toshiba said.